We have finished the collaboration with the Memorial Sloan-Kettering Cancer Center of New York by financing a research on Retinoblastoma managed by Dr. David Abramson and his team. This is the most common malignant cancer of the eye in children. For more than 100 years the only treatment was the removal of the eye; but in this new research, Dr Abramson has demonstrated that this technique is no longer necessary and that 95% of the eyes treated can be saved.
Collaboration with APNEEF 2023
In 2023, Invest for children collaborated with APNEEF to support a group of students with intellectual disabilities in their end-of-studies trip. The Association of People with Special Needs of Ibiza…
see project 
